Brought to you by Nucleus Regenerative Therapies
a new point of attack
Equine Osteoarthritis is a complex disease that requires a multifaceted approach. And now, equine veterinarians have a new product that addresses the root cause of joint pain by reducing friction. Noltrex®Vet has the ability to complement standard joint care treatment protocols by addressing the complex issue of joint pain from a physical as opposed to a pharmaceutical angle. The reduction of pain and inflammation are secondary effects resulting from improved physical joint lubrication.
provides durable physical protection to the joint surfaces, unlike products that simply mask symptoms such as inflammation and pain.
is not an analgesic nor an anti-inflammatory agent. It’s a 100% synthetic biocompatible molecule with neither immunogenic, nor antigenic properties. It does not require a chemical reaction nor metabolization to be effective within the joint.
remains in the joint longer than commonly used pharmaceuticals or supplements, thus providing long-term relief. Fewer interventions saves time and money, also reducing the risks associated with intra-articular joint injections.
provides sustained lubrication
By mechanically protecting the joint and reducing friction, Noltrex®Vet mitigates a root cause of sore joints. The polyacrylamide hydrogel contained in Noltrex®Vet mimics the viscoelastic properties of synovial fluid and provides synthetic joint lubrication.
“Works well and delivers a sustained response, especially in cases involving joint surface abnormalities, such as: Fibrilated Cartilage, Cartilage Defects and Subchondral Bone Cysts”